Page last updated: 2024-10-31

methyl methanesulfonate and Breast Neoplasms

methyl methanesulfonate has been researched along with Breast Neoplasms in 12 studies

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"In MCF-7 breast cancer cells, MMTS induced movement of endogenous BRCA1 into distinctive nuclear foci that co-stained with the SSB repair protein XRCC1, but not the DSB repair protein gamma-H2AX."1.34Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage. ( Au, WW; Henderson, BR, 2007)
"To evaluate its efficacy in sensitizing breast cancer cells to chemotherapy, MPG has been overexpressed in the breast cancer cell line, MDA-MB231."1.32Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing. ( Fishel, ML; Kelley, MR; Seo, YR; Smith, ML, 2003)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's4 (33.33)29.6817
2010's2 (16.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Lowder, LL1
Powell, M1
Miller, SE1
Kishton, RJ1
Kelly, CB1
Cribb, CB1
Mastro-Kishton, K1
Chelvanambi, M1
Do, PT1
Govindapur, RR1
Wardell, SE1
McDonnell, DP1
Bartolotti, LJ1
Akkaraju, GR1
Frampton, AR1
Varadarajan, S1
Harris, C1
Savas, J1
Ray, S1
Shanle, EK1
Hill, SJ1
Clark, AP1
Silver, DP1
Livingston, DM1
Chou, WC1
Hu, LY1
Hsiung, CN1
Shen, CY1
Fishel, ML1
Seo, YR1
Smith, ML3
Kelley, MR2
Rinne, M1
Caldwell, D1
Li, J1
Zou, C1
Bai, Y1
Wazer, DE1
Band, V1
Gao, Q1
Au, WW1
Henderson, BR1
Fan, S2
Rivet, DJ1
Duba, D1
Zhan, Q2
Kohn, KW1
Fornace, AJ2
O'Connor, PM2
Bae, I1
Yu, K1
Alamo, I1
Fujimori, A1
Gupta, M1
Hoki, Y1
Pommier, Y1
Chen, PL1
Chen, CF1
Chen, Y1
Xiao, J1
Sharp, ZD1
Lee, WH1

Other Studies

12 other studies available for methyl methanesulfonate and Breast Neoplasms

ArticleYear
Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer Cells.
    Journal of medicinal chemistry, 2021, 09-09, Volume: 64, Issue:17

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA Methylation; Drug Deli

2021
Yeast-based screening of cancer mutations in the DNA damage response protein Mre11 demonstrates importance of conserved capping domain residues.
    Molecular biology reports, 2021, Volume: 48, Issue:5

    Topics: Adenocarcinoma; Breast Neoplasms; DNA Damage; DNA Repair; Early Detection of Cancer; Endodeoxyribonu

2021
BRCA1 pathway function in basal-like breast cancer cells.
    Molecular and cellular biology, 2014, Volume: 34, Issue:20

    Topics: BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Replication; Fem

2014
Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Carcinogenesis, 2015, Volume: 36, Issue:8

    Topics: Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; Cell Line; Checkpoint Kinase 2; DNA Damage

2015
Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.
    Cancer research, 2003, Feb-01, Volume: 63, Issue:3

    Topics: Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Breast Neoplasms; Caspase 3; Caspases; Cel

2003
Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:8

    Topics: Adenoviridae; Alkylating Agents; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Br

2004
DSS1 is required for the stability of BRCA2.
    Oncogene, 2006, Feb-23, Volume: 25, Issue:8

    Topics: Blotting, Western; BRCA2 Protein; Breast Neoplasms; DNA Damage; Female; Genomic Instability; Humans;

2006
Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Cellular signalling, 2007, Volume: 19, Issue:9

    Topics: Alkylating Agents; Amino Acid Sequence; Ataxia Telangiectasia Mutated Proteins; BRCA1 Protein; Breas

2007
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
    Cancer research, 1995, Apr-15, Volume: 55, Issue:8

    Topics: Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Cisplatin; Clone Cells; Doxorubicin; Etoposid

1995
Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation.
    DNA and cell biology, 1996, Volume: 15, Issue:10

    Topics: Animals; Breast Neoplasms; Carcinoma, Large Cell; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell

1996
Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.
    Molecular pharmacology, 1996, Volume: 50, Issue:6

    Topics: Breast Neoplasms; Camptothecin; Cell Cycle; DNA Damage; DNA Repair; DNA Topoisomerases, Type I; Drug

1996
The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, Apr-28, Volume: 95, Issue:9

    Topics: BRCA2 Protein; Breast Neoplasms; DNA Damage; DNA Repair; DNA-Binding Proteins; DNA, Complementary; D

1998